Five Prime Therapeutics Announces FPA144 Will Be Featured

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Five Prime Therapeutics Announces FPA144 Will Be Featured During a Special Session at the 2016 AACR Annual Meeting

SOUTH SAN FRANCISCO, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq: FPRX ), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, announced that it will present the FPA144 program during a special session at the 2016 American Association for Cancer Research (AACR) Annual Meeting, being held April 16-20 in New Orleans.

The presentation, titled “ FPA144: A Therapeutic Monoclonal Antibody with Enhanced Antibody Dependent Cell Killing for the Treatment of Fibroblast Growth Factor Receptor 2b Overexpressing Cancers,” will take place during the session titled “ New Drugs on the Horizon” on Sunday, April 17, at 5:51 PM (CDT). The presentation will be made available on the publications page of the Five Prime website following the presentation.

About FPA144 FPA144 is an anti-FGF receptor 2b (FGFR2b) humanized monoclonal antibody in clinical development as a targeted immune therapy for tumors that over-express FGFR2b, as determined by a proprietary immunohistochemistry (IHC) diagnostic assay. FPA144 is designed to block tumor growth through two distinct mechanisms. First, it binds specifically to FGFR2b and prevents the binding of certain fibroblast growth factors that promote tumor growth. Second, it has been engineered to drive immune-based killing of tumor cells by antibody-dependent cell-mediated cytotoxicity (ADCC) and the recruitment of natural killer (NK) cells. FGFR2 gene amplification (as identified by FISH) is found in a number of tumors, including in approximately 5% of gastric cancer patients, and is associated with poor prognosis. 

About Five Prime Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and preclinical development. For more information, please visit www.fiveprime.com .

Cautionary Note on Forward-looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on Five Prime's expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from these forward-looking statements. Factors that may cause actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Five Prime's filings with the U.S. Securities and Exchange Commission, including the "Risk Factors" contained therein. Except as required by law, Five Prime assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.

CONTACT: Heather Rowe Investor Relations 415-365-5737 heather.rowe@fiveprime.com Amy Kendall Corporate Communications 415-365-5776 amy.kendall@fiveprime.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innogen's Arcera Deal Tests Its GLP-1 Global Reach

Updated Category News Views 32

A License Deal With Actual Cash Attached Drug licensing announcements can smell like expensive perfume: plenty of promise, hard to tell what is really in the bottle. This one at least arrives with a concrete number. Innogen Pharmaceuticals will receive US$38 million in upfront and near-term milestone payments from Arcera Life Sciences for Efsubaglutide Alfa, including a...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 24

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 56

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
Shenzhen's Vertical Factories Put Robotics on Fast Track

Updated Category News Views 44

A truck climbing to a ninth-floor factory is the sort of detail that cuts through the usual innovation fog. Shenzhen's Honghualing industrial base in Nanshan is built around that odd-looking reality: keep engineers, component makers, automated lines and test customers stacked close together, then squeeze time out of the process. For anybody watching robotics, LiDAR and...

Continue Reading
Wallstreet Sand Hands Its Massive Permian Plant to Wilbanks

Updated Category News Views 210

A sand plant can brag about acreage and horsepower all day, but frac crews remember who kept material arriving when a completion schedule got ugly. That is the real backdrop to PI Holdings and Wallstreet Sand Co. naming Blaine Wilbanks president of both businesses on November 18, 2026. This is not a ceremonial chair swap. Wallstreet has built an enormous Permian sand...

Continue Reading
LLCP Backs Empower in UK Infrastructure Services Push

Updated Category News Views 136

A majority cheque has landed in a business built around unglamorous work that cannot be wished away: keeping mechanical and electrical systems installed, refurbished and maintained. On November 18, LLCP said it completed a majority investment in London-headquartered Empower Technical Services alongside chief executive Nicholas Manning, co-founders Florian Kronawitter and...

Continue Reading
GE Aerospace Backs Service Members With $100K Gift

Updated Category News Views 106

A six-figure commitment can look tiny beside jet-engine budgets, yet it can matter a great deal when it reaches people navigating the awkward jump from military service into civilian life. GE Aerospace has committed $100,000 to Embry-Riddle Aeronautical University to support transitioning service members. That is the whole heart of this announcement, and frankly, it is...

Continue Reading
Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 82

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 20

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
GomSpace's €8M Lunar Deal Pushes Mission Ambitions

Updated Category News Views 41

Moon hardware is where small-space dreams either grow teeth or chew through cash, and GomSpace has just taken another meaningful bite. The company has secured an €8 million, or 89.1 million Swedish kronor, contract for the second phase of a lunar mission program with an unnamed leading North American space company. For GOMX, this is not some vague laboratory...

Continue Reading

Top 5 Most Recently Viewed Articles

TCL NXTPAPER 70 Pro: Pioneering Eye-Care Technology Innovation

Updated Category News Views 159

TCL NXTPAPER 70 Pro Takes Center Stage at Award Ceremony TCL, a renowned name in the display technology sector, has recently celebrated a significant achievement. The TCL NXTPAPER 70 Pro smartphone has been awarded the esteemed Eye-Care Display Technology Gold Award during a prestigious ceremony. This momentous occasion unfolded at the renowned Global Top Brands Awards...

Continue Reading
Sky Quarry Advances Its Waste Asphalt Shingle Facility Plans

Updated Category News Views 97

Sky Quarry Advances Its Waste Asphalt Shingle Facility Plans Sky Quarry Inc. (NASDAQ: SKYQ) is making significant strides toward enhancing the waste-to-energy industry with its innovative Waste Asphalt Shingle Modular Facility. Situated in Woods Cross, Utah, this facility is currently at an impressive stage of completion, standing at 80%. This marks a pivotal moment for...

Continue Reading
Bell Canada’s Strategic Move to Redeem Debentures Early

Updated Category News Views 322

Bell Canada Announces Early Redemption of Debentures Bell Canada recently made an important announcement regarding its financial strategies that speak volumes about its commitment to prudent management. The company revealed plans to redeem its outstanding Cdn $750 million principal amount of 3.55% Debentures, Series M-41, before their maturity date. This redemption is set...

Continue Reading
Exciting Housing Announcement: Key Insights for Communities

Updated Category News Views 174

Anticipating New Housing Developments Media outlets are set to cover an important housing announcement with significant implications for local communities. This event highlights the collaboration between government officials and community leaders focused on addressing housing needs and enhancing infrastructure in various regions. Key Officials Present at the Event The...

Continue Reading
Innovative Partnership Aims at Transforming Material Research

Updated Category News Views 284

Exciting Collaboration to Enhance Material Research In a groundbreaking partnership, CAS, a division of the American Chemical Society, has joined forces with PetroChina Shanghai Advanced Materials Research Institute Co., Ltd. This collaboration aims to utilize the CAS SciFinder Discovery Platform™ to expedite the research and development of advanced chemical materials....

Continue Reading